当前位置:首页 - 行情中心 - 三星医疗(601567) - 财务分析

三星医疗

(601567)

  

流通市值:321.65亿  总市值:321.66亿
流通股本:14.05亿   总股本:14.05亿

三星医疗(601567)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润12.15亿元,每股收益0.87元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益1241006.78万元,未分配利润685832.83万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产2324656.75万元,负债1083649.96万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入7,972,213,807.133,630,793,866.3114,600,478,206.1210,433,714,281.29
营业总成本6,798,039,087.953,129,719,427.7312,231,892,536.688,580,662,700.55
其他经营收益
营业利润1,381,832,722.13567,140,535.342,585,133,167.22,076,643,248.42
利润总额1,401,225,534.45568,591,856.182,672,556,622.62,117,707,156.34
净利润1,214,913,297.1480,485,140.962,273,237,462.351,822,779,409.65
每股收益
其他综合收益44,675,974.2714,203,090.27-3,372,669.31,812,403.58
综合收益总额1,259,589,271.37494,688,231.232,269,864,793.051,824,591,813.23
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计12,113,369,983.5213,652,778,344.6113,799,708,831.4611,269,490,609.45
非流动资产:
非流动资产合计11,133,197,466.8310,877,442,319.2410,676,777,755.4710,039,195,179.44
资产总计23,246,567,450.3524,530,220,663.8524,476,486,586.9321,308,685,788.88
流动负债:
流动负债合计9,099,227,634.337,568,086,008.097,810,359,014.987,704,905,672.71
非流动负债:
非流动负债合计1,737,271,970.784,153,885,006.624,392,189,417.121,726,260,609.33
负债合计10,836,499,605.1111,721,971,014.7112,202,548,432.19,431,166,282.04
所有者权益(或股东权益):
归属于母公司股东权益合计12,163,751,451.3512,590,896,965.1312,081,698,336.2711,700,018,960.94
股东权益合计12,410,067,845.2412,808,249,649.1412,273,938,154.8311,877,519,506.84
负债和股东权益合计23,246,567,450.3524,530,220,663.8524,476,486,586.9321,308,685,788.88
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计6,382,448,016.253,034,317,675.116,356,780,728.039,788,478,776.79
经营活动现金流出小计6,441,704,293.193,182,751,953.5814,520,596,284.378,759,266,819.54
经营活动产生的现金流量净额-59,256,276.94-148,434,278.481,836,184,443.661,029,211,957.25
投资活动产生的现金流量:
投资活动现金流入小计5,294,866,108.53,598,842,167.41,649,942,466.89357,018,810.02
投资活动现金流出小计5,060,947,294.394,138,136,988.873,676,681,277.73997,951,195.98
投资活动产生的现金流量净额233,918,814.11-539,294,821.47-2,026,738,810.84-640,932,385.96
筹资活动产生的现金流量:
筹资活动现金流入小计1,466,320,508.08186,824,435.724,168,259,423.7991,114,278.7
筹资活动现金流出小计3,322,976,017.7690,919,418.464,797,473,280.774,204,190,201.65
筹资活动产生的现金流量净额-1,856,655,509.6895,905,017.26-629,213,857.07-3,213,075,922.95
汇率变动对现金及现金等价物的影响-19,449,773.8948,560,723.57-82,220,480.64-30,405,018.39
现金及现金等价物净增加额-1,701,442,746.4-543,263,359.12-901,988,704.89-2,855,201,370.05
期末现金及现金等价物余额2,439,254,427.033,597,433,814.314,140,697,173.432,187,484,508.27
补充资料:
现金及现金等价物的净增加额-1,701,442,746.4--901,988,704.89-
最新报告期:2025-08-26
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信证券华夏,陈竹,华鹏伟,沈睦钧1.842.212.642025-08-26
国信证券王晓声,王蔚祺1.802.262.852025-08-25
东吴证券冉胜男,曾朵红,朱国广1.792.182.692025-08-22
野村东方国际证券李沛雨,马晓明1.822.242.682025-08-22
国金证券姚遥1.852.232.672025-08-21
TOP↑